Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
New York University Medical Center, NY, USA.
Antidepressants or stimulants are commonly used to treat attention deficit disorder (ADD). We report the results of an open-label trial of the recently marketed antidepressant venlafaxine in 16 adult patients with ADD. Patients were treated with venlafaxine (25 to 225 mg/day) for 8 weeks. Four patients discontinued treatment within the first week because of sedation, agitation, or nausea. In the remaining 12 patients, venlafaxine treatment decreased ADD ratings by almost half.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on